Search
Thursday 24 September 2015
  • :
  • :
Latest Update

Worth Watching Stocks: ZIOPHARM Oncology Inc. (NASDAQ:ZIOP), Citrix Systems, Inc. (NASDAQ:CTXS), General Mills, Inc. (NYSE:GIS), CBL & Associates Properties, Inc. (NYSE:CBL)

On Friday, ZIOPHARM Oncology Inc. (NASDAQ:ZIOP)’s shares inclined 5.71% to $12.59.

ZIOPHARM Oncology, Inc. (ZIOP), a biopharmaceutical company focused on the development and commercialization of new cancer immunotherapies, declared the presentation of clinical and preclinical data from the Company’s Ad-RTS-IL-12 program in various malignancies at the CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference took place September 16-19, 2015 in New York City. Ad-RTS-IL-12 is a novel gene therapy candidate for the controlled expression of IL-12, a critical protein for stimulating an anti-cancer T cell immune response.

The first poster presentation, titled, “Demonstration of Systemic Antitumor Immunity via Intratumoral Regulated Expression of IL-12 in Advanced Breast Cancer and Melanoma Patients,” highlights additional evidence of systemic immune activation with AD-RTS-hIL-12 and veledimex in advanced melanoma and breast cancer patients. The data were drawn from two formerly accomplished open-label Phase II clinical studies: one which enrolled 12 patients with metastatic advanced stage breast cancer, and one which enrolled 26 patients with metastatic melanoma, both exploring the immune-mediated local and systemic anti-tumor effects of Ad-RTS-hIL-12 and veledimex. Among other findings, treatment with Ad-RTS-hIL-12 and veledimex in patients with melanoma was found to enhance in the immune cytokine IL-12 and downstream cytokines, IFNg, IP-10 and IL-10, resulting in a noteworthy enhance in tumor infiltrating lymphocytes both locally, in injected lesions, and systemically, in non-injected lesions.

ZIOPHARM Oncology, Inc., a biotechnology company, employs gene expression, control, and cell technologies to deliver cell-based therapies for the treatment of cancer. Its synthetic immuno-oncology programs, in partnership with Intrexon Corporation and the MD Anderson Cancer Center, comprise chimeric antigen receptor T cell (CAR-T) and other adoptive cell based approaches that use both non-viral and viral gene transfer methods for broad scalability.

Citrix Systems, Inc (NASDAQ:CTXS)’s shares dropped -1.08% to $72.30.

Citrix declared that Kimberly Martin is joining the company as vice president of partner strategy and sales, reporting to Carlos Sartorius, senior vice president, worldwide sales and services. As the new worldwide channel leader, Martin will be responsible for evolving the company’s partner strategy for ISVs, OEMs, SIs, service providers, resellers, and distributors, addressing channel needs, delivering maximum value to partners and driving customer success. Martin’s appointment is part of a broader sales transformation plan that was initiated earlier this year.

Martin brings with her an extensive background in channel program design and development, partner marketing and channel incentive design. Most recently, she was vice president of worldwide business development and partner at Datameer where she built a partner ecosystem and established partner programs in the new Hadoop technology space. She has also served as vice president of worldwide channels at Informatica, and led Microsoft’s EMEA channel business for several years. While at Microsoft, Martin offered leadership for the channel through the move from on-prem perpetual licensing to cloud-based services for Microsoft’s EMEA market. Formerly, she worked at Andersen Consulting and then Accenture consulting on sales and channel transformation for technology companies counting EMC, Cisco, Dell, HP, among others.

Citrix Systems, Inc. provides virtualization, mobility administration, networking, and Software as a Service solutions worldwide. The company’s Enterprise and Service Provider division offers XenMobile Enterprise, a solution to manage mobile devices, apps, and data; XenDesktop, a desktop virtualization system that gives customers the flexibility to deliver desktops and applications as cloud services; Citrix XenApp that allows Windows applications to be delivered as cloud services to Android and iOS mobile devices, Macs, PCs, and thin clients; and Citrix Operatespace Suite, a business mobility solution that delivers the user experience for any app or desktop.

At the end of Friday’s trade, General Mills, Inc. (NYSE:GIS)‘s shares dipped -1.55% to $56.59.

Recently General Mills declared the re-launch of its new and improved digital platform, QueRicaVida.com. Harnessing the power of innovation and mobile technology, General Mills is creating a brand new site and mobile experience to meet the needs of the new Latina and her mobile lifestyle.

According to a study by IAB, Latina moms are leading mobile first lives with nearly 40 percent of Latina moms relying on mobile devices as their primary internet source. With social, digital and mobile playing an important role in their everyday lives, General Mills redesigned their new site to be socially intuitive and mobile friendly.

The improved website has more rich, diverse and relevant content and offers valuable recipes, savings and nutritional information in a way that is more convenient for consumers.

Contemporary Design
The site was created with mobile efficiency in mind. The clean, clear, fluid design makes cooking from any smartphone easier and more enjoyable allowing the user to quickly note ingredients and instruction in addition to share, pin and favorite preferred recipes.

Rich Content and Intuitive Navigation
Authentic recipes and relevant articles are now just a couple of simple clicks away. In catering to the consumer and their values of family, diversity and health, QueRicaVida.com now hosts richer and more diverse dishes that celebrate heritage, culture and wellness while also offering fluid and intuitive navigation making exploring and discovering recipes a pleasant experience.

General Mills, Inc. manufactures and markets branded consumer foods in the United States and internationally. It also supplies branded and unbranded food products to the foodservice and commercial baking industries. The company operates in three segments: U.S. Retail, International, and Convenience Stores and Foodservice.

CBL & Associates Properties, Inc. (NYSE:CBL), ended its Friday’s trading session with -1.15% loss, and closed at $14.62.

CBL & Associates Properties, Inc. and PLAYTIME, LLC are happy to declare a multi-year partnership with Fisher-Price, Inc., one of the world’s leading infant and preschool toy manufacturers, and a partner of Mattel, Inc., to design soft play area attractions at select CBL centers nationwide.

The play areas will resemble a larger-than-life Toy Box featuring iconic brands like Thomas & Friends™, Little People® and more. PLAYTIME, LLC, long-time partner of CBL, will bring these highly recognizable and well-loved characters to life in interactive, engaging attractions exclusive to CBL malls.

The five-year partnership kicks off this fall with the first three attractions opening at West Towne Mall in Madison, WI; Asheville Mall in Asheville, NC; and Monroeville Mall in Monroeville, PA, just in time for the 2015 holiday season. Three additional attractions will open in early 2016, and locations will be declared in the coming months. Over the next three years, the partnership is planned to extend to more than 18 malls across the country.

CBL & Associates Properties, Inc. is a public real estate investment trust. It engages in acquisition, development, and administration of properties. The fund invests in the real estate markets of United States. Its portfolio comprises of enclosed malls and open-air centers. CBL & Associates Properties is based in Oak Brook, Illinois.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.




Leave a Reply

Your email address will not be published. Required fields are marked *